| Name | Title | Contact Details |
|---|
Jordan & Skala Engineers is a leading consulting-engineering firm that specializes in mechanical, electrical, and plumbing (MEP) engineering services. Founded in 1953 and headquartered in Norcross, GA, the company operates multiple regional design offices across the United States, allowing it to effectively meet the diverse needs of its clients. With a workforce of approximately 310 employees, Jordan & Skala Engineers is licensed to operate in all 50 states. The firm offers a wide range of services, including MEP engineering, structured cabling for communications, security system design, audio-visual solutions, and comprehensive energy services aimed at promoting sustainability. Additionally, the company conducts facility assessments to optimize existing buildings. Jordan & Skala Engineers is committed to engineering excellence, focusing on quality, safety, and strong client relationships through teamwork and innovative designs. The company has been recognized as a Top U.S. Workplace in 2023, underscoring its dedication to employee satisfaction and industry leadership.
It is the mission of Veterans Legal Services to help Massachusetts veterans overcome adversity by providing free civil legal aid that honors their service, promotes well-being, and responds to their distinctive needs. Veterans Legal Services (VLS) is a 501(c)3 non-profit organization and is the leader in providing free legal advice and representation to homeless and low-income veterans in the Greater Boston area and serves over 500 veterans cases per year at its legal clinics. By locating legal clinics at homeless shelters and service centers, VLS reaches members of our society who are often reluctant to seek legal help and is able to partner with shelter staff to provide holistic support. During its legal clinics, VLS staff attorneys supervise volunteer law students who perform client intakes. After determining eligibility and performing due diligence, VLS offers the veteran either on-the-spot advice, brief service such as helping with pleadings, or full legal representation, up to and including representing the veteran in court or in front of state/federal agencies. VLS is the only legal aid organization in Massachusetts whose mission is to serve veterans. VLS prioritizes veterans where legal representation may yield a life-changing result that restores a veterans self-sufficiency and dignity. We prioritize cases for the disabled, victims of domestic violence, and cases where there is a significant disparity in resources or the opposing party has representation. Veterans Legal Services serves over 500 veterans cases per year at its legal clinics. Previously known as Shelter Legal Services, in late 2013 we began doing business as Veterans Legal Services to better reflect our mission of serving those who serve our country.
Bridge Specialty Group, LLC was launched in February 2021 by Brown & Brown, Inc. to encompass its broad portfolio of wholesale insurance businesses and is focused on bringing the power of its collective size and specialty to the wholesale brokerage marketplace. Composed of more than 25 boutique brands, Bridge Specialty Group is creating a more seamless way to connect the varying needs of our retail partners with the market clout and talents of our wholesale entities. To learn more about Bridge Specialty Group and our team of niche-focused brands, visit our website at bridgespecialtygroup.com.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
As of December 31st, 2023, the XFL has officially merged with the USFL to create the United Football League (UFL). Our spring football legacy continues in 2024 under a new name, with the same goal: to make the spring football opportunity as strong as it can be. See you at a game! theUFL.com/tickets